亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Antibodies against human CEACAM1 gemeinsam mit 4782

總結
Monoclonal antibodies for research, which are specific for CEACAM1. In contrast to available antibodies the two antibodies exhibit a high affinity and specificity for the A1/B-domains of human CEACAM1 and do not bind to other members of the family of CEACAM-family.
技術優勢
Monoclonal antibody directed against the A1/B-domains of human CEACAM1
High affinity and mono-specificity
Detect membrane anchored and soluble human CEACAM1 and most of its derivatives
Suitable for numerous applications:
> in cancer research
> in diagnosis
> in therapy monitoring
>as immunmodulator in the therapy of tumors, infections and inflammations
技術應用
Suitable to detect the membrane anchored, the cleaved soluble CEACAM1 and most of its derivatives. It is of use in several research applications, including ELISA, WB, IP, IHC, fluorescence microscopy and flow cytometry.
詳細技術說明
Due to the structural similarity it is very challenging to obtain antibodies against specific CEACAM1-domains. CEACAM1 has been detected at elevated levels in the surrounding tissue of tumors and the tumors themselves. It appears that CEACAM1 is a suitable biomarker for the diagnosis and staging of tumors.
合作類型
Licensing
申請日期
22/06/2010 00:00:00
申請號碼
DE20101024636 20100622
分類
- international:
C07K16/28; C12N5/12; G01N33/53
- cooperative:
C07K16/30; M68G01N33/K6957434; G01N2333/70596
其他
Patent application
ID號碼
2401
國家/地區
德國

欲了解更多信息,請點擊 這裡
移動設備